# 6R-BH4 Pulmonary Arterial Hypertension Study

> **NCT00435331** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 14 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** sapropterin dihydrochloride (6R-BH4)

## Key facts

- **NCT ID:** NCT00435331
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-09
- **Final completion:** 2008-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-06-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435331, "6R-BH4 Pulmonary Arterial Hypertension Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00435331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*